Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.

Julia Rose SalinaroKourtnie McQuillenMegan StempleRobert BoccaccioJessie EhrismanAmelia M LorenzoLaura HavrileskyAngeles Alvarez SecordValerie Galvan TurnerKathleen Nadine MooreBrittany Davidson

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)

Patients with advanced ovarian cancer are at high risk for venous thromboembolism while receiving neoadjuvant chemotherapy. Consideration of thromboprophylaxis may be warranted.

Keyphrases

neoadjuvant chemotherapy
venous thromboembolism
direct oral anticoagulants
locally advanced
lymph node
sentinel lymph node
risk factors
rectal cancer
squamous cell carcinoma
early stage
atrial fibrillation